Nancy E Kemeny MD

Oncology•New York, NY

Attending Physician, Memorial Sloan-Kettering Cancer Center

Join to View Full Profile

Memorial Sloan Kettering Cancer Center New York1275 York AvenueNew York, NY 10021

Education & Training

New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1974 - 1976
New York Medical College at St Vincent's Hospital and Medical Center of New YorkResidency, Internal Medicine, 1971 - 1974
Rutgers New Jersey Medical SchoolClass of 1971

Certifications & Licensure

FL State Medical License 2021 - Present
NJ State Medical License Active through 2025
NY State Medical License 1972 - 2025
VT State Medical License 2022 - 2024
NC State Medical License 2020 - 2022
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

New York Magazine: Top Doctors Castle Connolly, 2002-2014
America's Top Doctors Castle Connolly, 2002-2014
Top Doctors: New York Metro Area Castle Connolly, 2002-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Men's Health Castle Connolly, 2007
Fellow (FASCO) American Society of Clinical Oncologists, 2007
Join now to see all

Clinical Trials

Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer Start of enrollment: 1996 Jan 01
Completed
Phase 3
Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer Start of enrollment: 1998 Apr 01
Completed
Phase 1
Floxuridine, Dexamethasone, and Irinotecan After Surgery in Treating Patients With Liver Metastases From Colorectal Cancer Start of enrollment: 1998 Sep 01
Completed
Phase 2
Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer Start of enrollment: 2000 Aug 01
Completed
Phase 1
Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer
COMPLETED
PHASE1
Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer Start of enrollment: 2004 Nov 19
COMPLETED
PHASE2
Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver
ACTIVE_NOT_RECRUITING
PHASE2
Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal Cancer Start of enrollment: 2000 Aug 01
Completed
Phase 1
Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer Start of enrollment: 2011 Mar 07
COMPLETED
PHASE2
A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma Start of enrollment: 2018 Oct 18
COMPLETED
PHASE2
Join now to see all

Publications & Presentations

PubMed

ASO Visual Abstract: Outcomes of First-versus Second-Line Hepatic Artery Infusion Chemotherapy in Unresectable Intrahepatic Cholangiocarcinoma.
Naaz Nasar, Misha Armstrong, Joanne F Chou, Mithat Gonen, Kevin C Soares
Annals of Surgical Oncology. 2025-11-17
ASO Visual Abstract: Hepatic Recurrence Rate Based on Extent of Adjuvant Floxuridine Exposure After Resection of Colorectal Liver Metastases.
Omar A Zaki, Raja R Narayan, Rami Srouji, Thomas Boerner, Kenneth Seier
Annals of Surgical Oncology. 2025-11-10
Hepatic Recurrence Rate Based on Extent of Adjuvant Floxuridine Exposure After Resection of Colorectal Liver Metastases.
Omar A Zaki, Raja R Narayan, Rami Srouji, Thomas Boerner, Kenneth Seier
Annals of Surgical Oncology. 2025-10-30

Journal Articles

Quantitative Imaging Features of Pretreatment CT Predict Volumetric Response to Chemotherapy in Patients with Colorectal Liver Metastases
Andrea Cercek, William R Jarnagin, Jinru Shia, Peter J Allen, Kenneth P Seastedt, Nancy E Kemeny, Ronald P DeMatteo, Vinod P Balachandran, T Peter Kingham, European Radiology

Lectures

Randomized phase II trial of adjuvant hepatic arterial infusion (HAI) + systemic FOLFIRI +/- panitumumab (Pmab) in patients with resected RAS wild type colorectal canc...
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

Doctors Fret as Firm Stops Making Cancer Drug PumpApril 26th, 2018
Liver-Directed Therapy Shows Improvement in mCRCJanuary 5th, 2018

Grant Support

Therapy Of Hepatic Metastases From Colorectal CarcinomaNational Cancer Institute1993–2001
ST Vincent'S Community Clinical Oncology ProgramNational Cancer Institute1987–1989